Blogpost

Breaking Down Barries in the Specialty Patient Journey with Yishai Knobel

Our founder, Yishai Knobel was recently featured on the Empowered Patient Podcast with Karen Jagoda where he talked all things specialty and how the HelpAround gateway is helping patients get their drugs faster and stay on therapy longer. … Read More

Featured Post

As Apple rolls out medication tracking to all iPhones, pharma must embrace connectivity

Imagine visiting your doctor’s office. Instead of swiping a co-pay card and filling out a paper form by hand, the receptionist says, “Please bring your phone closer. We take Apple Health here.” You wave your iPhone over a digital kiosk, instantly uploading your current medical record and insurance information. Your co-pay is then deducted from a Health Savings Account. Voila! The doctor will see you now. … Read More

Featured Post

Meet the Disruptors: Yishai Knobel of HelpAround On The Five Things You Need To Shake Up Your Industry

Our founder, Yishai Knobel was recently interviewed by Fotis Georgiadis, a staff writer for Authority Magazine, a Medium publication, devoted to sharing in-depth, and interesting interviews, featuring people who are authorities in Business, Pop Culture, Wellness, Social Impact, and Tech. … Read More

Featured Post

In the current venture climate, tech for pharma is recession-proof

Among the world’s top 20 pharmaceutical companies, ranked according to their 2021 revenue, 19 generate most of their sales from specialty medicines. Overall, 55 percent of pharmaceutical revenues are driven by specialty drugs. This basic fact about how prescription drug companies make money is mostly lost on the general public, but is instructive for understanding how the entire industry works, and why it is relatively recession-proof. … Read More

Featured Post

Beyond DocuSign: How to Upgrade Specialty Drug Patients to a First-class Experience

Imagine booking a luxury international vacation. A dedicated concierge arranges your hotels, your travel arrangements, and your daily itinerary. You barely lift a finger. … Read More

Featured Post

For specialty treatments, collaborative platforms are the future

The specialty patient journey is currently at a major inflection point—and where this all lands will intrigue anyone drawn to the remarkable rise of digital collaboration platforms.  … Read More

Featured Post

What makes for a unicorn in the Rx value chain? Part 1: CoverMyMeds

Over the past ten years, retail Rx networks have matured and the winners have emerged.  As we look forward to the next five to ten years, and as specialty drugs emerge as the dominant category,  the question arises whether the specialty … Read More

Featured Post

Shifts in $283B specialty pharma market present big opportunities

Within the $283 billion specialty pharma market, one critical but inefficient niche – specialty patient services –  has become an open target for disruption. A reckoning looms in 2022 for the beleaguered patient services sector, as two competing and unsustainable … Read More

Featured Post

Patient Support is Becoming More Holistic and Changes Are Needed

Patient support programs have evolved from purely assisting with the financial aspects of treatment to covering patients’ entire healing journeys. In the last few years, it’s become clear that the one-size-fits-all patient support model is ineffective, particularly when it comes … Read More

Featured Post

The Quick Skinny on 2021’s HUB, SPP & eServices Optimization Event

If you missed Hub SPP’s buzzy gathering, or if you just want a fresh refresh, this one’s for you. Whether you’re a manufacturer, specialty pharmacy, or hub provider, there was something for everyone at this year’s Hub SPP. We scoured the … Read More

Featured Post